(Q38003661)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

The investigation of severe asthma to define phenotypes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

D Gibeon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Allergy

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

678-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515390%20AND%20SRC:MED&resulttype=core&format=json

Risk factors and costs associated with an asthma attack

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Systematic assessment of difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Defining and investigating difficult asthma: developing quality indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Asthma-related comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Risk factors of frequent exacerbations in difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Factors associated with persistent airflow limitation in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

High frequency of atopic asthma in a pulmonary clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Atopic status in patients with brittle and non-brittle asthma: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

The link between fungi and severe asthma: a summary of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Severe Asthma with Fungal Sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

The links between chronic rhinosinusitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Abnormal vocal cord function in difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

The association between gastro-oesophageal reflux disease and asthma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Efficacy of esomeprazole for treatment of poorly controlled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Correlates of daytime sleepiness in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Sleep apnea: a proinflammatory disorder that coaggregates with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Obstructive airway disease and obstructive sleep apnea: effect of pulmonary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Nocturnal asthma: role of snoring and obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Impact of CPAP on asthmatic patients with obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Prevalence of psychiatric morbidity in a difficult asthma population: relationship to asthma outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Close correlation between anxiety, depression, and asthma control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Severe asthma in adults: what are the important questions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

The "steroid dementia syndrome": a possible model of human glucocorticoid neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Psychologic distress and maladaptive coping styles in patients with severe vs moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Clinical practice. Glucocorticoid-induced bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Nonadherence in Asthmatic Patients: Is there a Solution to the Problem ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

The prevalence of nonadherence in difficult asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Use of exhaled nitric oxide measurements to guide treatment in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Differences in airway cytokine profile in severe asthma compared to moderate asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Alterations of the arginine metabolome in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Mepolizumab and exacerbations of refractory eosinophilic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Eosinophilic bronchitis: clinical manifestations and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

A comparison of the validity of different diagnostic tests in adults with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Effects of steroid therapy on inflammatory cell subtypes in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Disordered microbial communities in asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Safety of investigative bronchoscopy in the Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Differences in airway remodeling between subjects with severe and moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Qualitative analysis of high-resolution CT scans in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

High-resolution computed tomography scan and airway remodeling in children with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Quantitative computed tomography detects air trapping due to asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Emergent behavior of regional heterogeneity in the lung and its effects on respiratory impedance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Importance of hedgehog interacting protein and other lung function genes in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Racial differences in biologic predictors of severe asthma: Data from the Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Obesity and asthma: cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Obesity and asthma: An association modified by age of asthma onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Detrimental Effects of Environmental Tobacco Smoke in Relation to Asthma Severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Corticosteroid insensitivity in severe asthma: significance, mechanisms and aetiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Cluster analysis and clinical asthma phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

An integrative systems biology approach to understanding pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

British Guideline on the Management of Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X

The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2012.03959.X